# TXO Partners, L.P.: financial statements, quarterly

TXO · NYSE · CIK 1559432 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/txo.md) · [Financials](/companies/txo/financials.md) · [Filings](/companies/txo/filings.md) · [Insiders](/companies/txo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/txo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [74.9](/filings/0001559432-24-000052.md) | [72.0 d](/filings/0001559432-26-000005.md) | [68.5](/filings/0001559432-25-000062.md) | [57.0](/filings/0001559432-25-000098.md) | [69.3](/filings/0001559432-25-000108.md) | [90.6 d](/filings/0001559432-26-000005.md) | [93.8](/filings/0001193125-26-204137.md) | [75.0](/filings/0001559432-26-000014.md) | [90.6](/filings/0001559432-25-000108.md) | [104 d](/filings/0001559432-26-000005.md) | [120](/filings/0001193125-26-204137.md) | [134](/filings/0001559432-26-000014.md) |
| Operating income | $m | [4.4](/filings/0001559432-24-000052.md) | [(198) d](/filings/0001559432-26-000005.md) | [2.7](/filings/0001559432-25-000062.md) | [(10.1)](/filings/0001559432-25-000098.md) | [(5.0)](/filings/0001559432-25-000108.md) | [5.5 d](/filings/0001559432-26-000005.md) | [(3.6)](/filings/0001193125-26-204137.md) | [(3.7)](/filings/0001559432-26-000014.md) | [3.8](/filings/0001559432-25-000108.md) | [(27.0) d](/filings/0001559432-26-000005.md) | [(77.6)](/filings/0001193125-26-204137.md) | [57.7](/filings/0001559432-26-000014.md) |
| Interest expense | $m | [1.2](/filings/0001559432-23-000037.md) | [1.2 d](/filings/0001559432-24-000011.md) | [1.0](/filings/0001559432-24-000020.md) | [1.0](/filings/0001559432-25-000098.md) | [1.9](/filings/0001559432-25-000108.md) | [4.0 d](/filings/0001559432-26-000005.md) | [3.6](/filings/0001193125-26-204137.md) | [2.6](/filings/0001559432-26-000014.md) | [4.5](/filings/0001559432-25-000108.md) | [6.3 d](/filings/0001559432-26-000005.md) | [5.7](/filings/0001193125-26-204137.md) | [5.6](/filings/0001559432-26-000014.md) |
| Net income | $m | [8.5](/filings/0001559432-24-000052.md) | [(194) d](/filings/0001559432-26-000005.md) | [10.3](/filings/0001559432-25-000062.md) | [2.8](/filings/0001559432-25-000098.md) | [0.2](/filings/0001559432-25-000108.md) | [10.2 d](/filings/0001559432-26-000005.md) | [2.4](/filings/0001193125-26-204137.md) | [(0.1)](/filings/0001559432-26-000014.md) | [4.4](/filings/0001559432-25-000108.md) | [(28.3) d](/filings/0001559432-26-000005.md) | [(74.3)](/filings/0001193125-26-204137.md) | [60.8](/filings/0001559432-26-000014.md) |
| Diluted EPS | $ per share | [0.27](/filings/0001559432-24-000052.md) | not reported | [0.33](/filings/0001559432-25-000062.md) | [0.09](/filings/0001559432-25-000098.md) | [0.01](/filings/0001559432-25-000108.md) | not reported | [0.06](/filings/0001193125-26-204137.md) | [0.00](/filings/0001559432-26-000014.md) | [0.08](/filings/0001559432-25-000108.md) | not reported | [(1.35)](/filings/0001193125-26-204137.md) | [1.07](/filings/0001559432-26-000014.md) |
| Basic EPS | $ per share | [0.28](/filings/0001559432-24-000052.md) | not reported | [0.33](/filings/0001559432-25-000062.md) | [0.09](/filings/0001559432-25-000098.md) | [0.01](/filings/0001559432-25-000108.md) | not reported | [0.06](/filings/0001193125-26-204137.md) | [0.00](/filings/0001559432-26-000014.md) | [0.08](/filings/0001559432-25-000108.md) | not reported | [(1.35)](/filings/0001193125-26-204137.md) | [1.10](/filings/0001559432-26-000014.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.9](/filings/0001559432-23-000037.md) | [4.5](/filings/0001559432-25-000035.md) | [4.6](/filings/0001559432-24-000020.md) | [76.0](/filings/0001559432-24-000045.md) | [3.8](/filings/0001559432-24-000052.md) | [7.3](/filings/0001559432-26-000005.md) | [10.8](/filings/0001559432-25-000062.md) | [8.0](/filings/0001559432-25-000098.md) | [5.3](/filings/0001559432-25-000108.md) | [9.4](/filings/0001559432-26-000014.md) | [7.9](/filings/0001193125-26-204137.md) | [107](/filings/0001559432-26-000014.md) |
| Current assets | $m | [52.2](/filings/0001559432-23-000037.md) | [55.2](/filings/0001559432-25-000035.md) | [53.9](/filings/0001559432-24-000020.md) | [117](/filings/0001559432-24-000045.md) | [54.1](/filings/0001559432-24-000052.md) | [64.4](/filings/0001559432-26-000005.md) | [81.6](/filings/0001559432-25-000062.md) | [70.8](/filings/0001559432-25-000098.md) | [76.9](/filings/0001559432-25-000108.md) | [95.3](/filings/0001559432-26-000014.md) | [90.2](/filings/0001193125-26-204137.md) | [179](/filings/0001559432-26-000014.md) |
| Total assets | $m | [901](/filings/0001559432-23-000037.md) | [696](/filings/0001559432-25-000035.md) | [688](/filings/0001559432-24-000020.md) | [775](/filings/0001559432-24-000045.md) | [1,016](/filings/0001559432-24-000052.md) | [1,031](/filings/0001559432-26-000005.md) | [1,033](/filings/0001559432-25-000062.md) | [1,047](/filings/0001559432-25-000098.md) | [1,376](/filings/0001559432-25-000108.md) | [1,355](/filings/0001559432-26-000014.md) | [1,322](/filings/0001193125-26-204137.md) | [1,251](/filings/0001559432-26-000014.md) |
| Current liabilities | $m | [60.7](/filings/0001559432-23-000037.md) | [39.1](/filings/0001559432-25-000035.md) | [39.7](/filings/0001559432-24-000020.md) | [35.8](/filings/0001559432-24-000045.md) | [53.1](/filings/0001559432-24-000052.md) | [66.3](/filings/0001559432-26-000005.md) | [82.0](/filings/0001559432-25-000062.md) | [72.7](/filings/0001559432-25-000098.md) | [161](/filings/0001559432-25-000108.md) | [154](/filings/0001559432-26-000014.md) | [210](/filings/0001193125-26-204137.md) | [171](/filings/0001559432-26-000014.md) |
| Long-term debt | $m | [25.1](/filings/0001559432-23-000037.md) | [28.1](/filings/0001559432-25-000035.md) | [26.1](/filings/0001559432-24-000020.md) | [7.1](/filings/0001559432-24-000045.md) | [155](/filings/0001559432-24-000052.md) | [157](/filings/0001559432-26-000005.md) | [162](/filings/0001559432-25-000062.md) | [19.1](/filings/0001559432-25-000098.md) | [271](/filings/0001559432-25-000108.md) | [291](/filings/0001559432-26-000014.md) | [277](/filings/0001193125-26-204137.md) | [270](/filings/0001559432-26-000014.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [24.2 d](/filings/0001559432-24-000052.md) | [17.4 d](/filings/0001559432-26-000005.md) | [25.2](/filings/0001559432-25-000062.md) | [22.9 d](/filings/0001559432-25-000098.md) | [20.7 d](/filings/0001559432-25-000108.md) | [40.5 d](/filings/0001559432-26-000005.md) | [30.6](/filings/0001193125-26-204137.md) | [26.9 d](/filings/0001559432-26-000014.md) | [28.3 d](/filings/0001559432-25-000108.md) | [32.5 d](/filings/0001559432-26-000005.md) | [33.4](/filings/0001193125-26-204137.md) | [49.1 d](/filings/0001559432-26-000014.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.0](/filings/0001559432-23-000037.md) | [29.3](/filings/0001559432-24-000020.md) | [30.8](/filings/0001559432-24-000045.md) | [31.3](/filings/0001559432-24-000052.md) | [31.4](/filings/0001559432-25-000062.md) | [31.7](/filings/0001559432-25-000098.md) | [39.8](/filings/0001559432-25-000108.md) | [41.8](/filings/0001193125-26-204137.md) | [48.2](/filings/0001559432-26-000014.md) | [55.8](/filings/0001559432-25-000108.md) | [55.1](/filings/0001193125-26-204137.md) | [56.7](/filings/0001559432-26-000014.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 55,446,407 at 2026-08-04, from the cover of the [10-Q filed 2026-08-04](/filings/0001559432-26-000014.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.